160 related articles for article (PubMed ID: 32462322)
1. Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database.
Kim J; Hyun HJ; Choi EA; Kim Y; Bae YJ; Kang HT
Gastric Cancer; 2020 Nov; 23(6):1075-1083. PubMed ID: 32462322
[TBL] [Abstract][Full Text] [Related]
2. Metformin use reduced the overall risk of cancer in diabetic patients: A study based on the Korean NHIS-HEALS cohort.
Kim YS; Choi EA; Lee JW; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kang HT; Kim J
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1714-1722. PubMed ID: 32753274
[TBL] [Abstract][Full Text] [Related]
3. Diabetes, Metformin, and Lung Cancer: Retrospective Study of the Korean NHIS-HEALS Database.
Kim J; Hyun HJ; Choi EA; Yoo JW; Lee S; Jeong N; Shen JJ; You HS; Kim YS; Kang HT
Clin Lung Cancer; 2020 Nov; 21(6):e551-e559. PubMed ID: 32532664
[TBL] [Abstract][Full Text] [Related]
4. Metformin use in elderly population with diabetes reduced the risk of dementia in a dose-dependent manner, based on the Korean NHIS-HEALS cohort.
Kim Y; Kim HS; Lee JW; Kim YS; You HS; Bae YJ; Lee HC; Han YE; Choi EA; Kim J; Kang HT
Diabetes Res Clin Pract; 2020 Dec; 170():108496. PubMed ID: 33068660
[TBL] [Abstract][Full Text] [Related]
5. Metformin Use May Increase Risk of Pancreatic Cancer in Diabetic Women: An Analysis of the Korean National Health Insurance Service-National Health Screening Cohort Database.
Kim J; Bae YJ; Kang HT
Korean J Fam Med; 2022 Sep; 43(5):327-333. PubMed ID: 36168905
[TBL] [Abstract][Full Text] [Related]
6. Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015.
Kim J; Bae YJ; Lee JW; Kim YS; Kim Y; You HS; Kim HS; Choi EA; Han YE; Kang HT
Medicine (Baltimore); 2021 Mar; 100(11):e25045. PubMed ID: 33725979
[TBL] [Abstract][Full Text] [Related]
7. The cumulative dose-dependent effects of metformin on the development of tuberculosis in patients newly diagnosed with type 2 diabetes mellitus.
Heo E; Kim E; Jang EJ; Lee CH
BMC Pulm Med; 2021 Sep; 21(1):303. PubMed ID: 34563159
[TBL] [Abstract][Full Text] [Related]
8. Metformin usage and the risk of colorectal cancer: a national cohort study.
Lee JW; Choi EA; Kim YS; Kim Y; You HS; Han YE; Kim HS; Bae YJ; Kim J; Kang HT
Int J Colorectal Dis; 2021 Feb; 36(2):303-310. PubMed ID: 32968891
[TBL] [Abstract][Full Text] [Related]
9. Metformin use and risk of COVID-19 among patients with type II diabetes mellitus: an NHIS-COVID-19 database cohort study.
Oh TK; Song IA
Acta Diabetol; 2021 Jun; 58(6):771-778. PubMed ID: 33582839
[TBL] [Abstract][Full Text] [Related]
10. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
Tseng CH
Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
[TBL] [Abstract][Full Text] [Related]
11. Metformin and Gastrointestinal Cancer Development in Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea.
You JH; Song SO; Kang MJ; Cho YY; Kim SW; Suh SH; Lee S; Lee YH; Lee BW
Clin Transl Gastroenterol; 2020 Nov; 11(11):e00254. PubMed ID: 33105165
[TBL] [Abstract][Full Text] [Related]
12. Protective Effect of Metformin Against Thyroid Cancer Development: A Population-Based Study in Korea.
Cho YY; Kang MJ; Kim SK; Jung JH; Hahm JR; Kim TH; Nam JY; Lee BW; Lee YH; Chung JH; Song SO; Kim SW
Thyroid; 2018 Jul; 28(7):864-870. PubMed ID: 29808777
[TBL] [Abstract][Full Text] [Related]
13. Long-term metformin use reduces gastric cancer risk in type 2 diabetics without insulin treatment: a nationwide cohort study.
Kim YI; Kim SY; Cho SJ; Park JH; Choi IJ; Lee YJ; Lee EK; Kook MC; Kim CG; Ryu KW; Kim YW
Aliment Pharmacol Ther; 2014 Apr; 39(8):854-63. PubMed ID: 24612291
[TBL] [Abstract][Full Text] [Related]
14. Metformin reduces the risk of cancer in patients with type 2 diabetes: An analysis based on the Korean National Diabetes Program Cohort.
Kim HJ; Lee S; Chun KH; Jeon JY; Han SJ; Kim DJ; Kim YS; Woo JT; Nam MS; Baik SH; Ahn KJ; Lee KW
Medicine (Baltimore); 2018 Feb; 97(8):e0036. PubMed ID: 29465545
[TBL] [Abstract][Full Text] [Related]
15. Statin use increased new-onset diabetes in hypercholesterolemic individuals: Data from the Korean National Health Insurance Service-National Health Screening Cohort database (NHIS-HEALS).
Kim YS; Han YE; Choi EA; You NY; Lee JW; You HS; Kim Y; Kim J; Kang HT
Prim Care Diabetes; 2020 Jun; 14(3):246-253. PubMed ID: 31548127
[TBL] [Abstract][Full Text] [Related]
16. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
Tseng CH
Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
[TBL] [Abstract][Full Text] [Related]
17. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
Tseng CH
Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
[TBL] [Abstract][Full Text] [Related]
18. Metformin and Cervical Cancer Risk in Patients with Newly Diagnosed Type 2 Diabetes: A Population-Based Study in Korea.
Kim HM; Kang MJ; Song SO
Endocrinol Metab (Seoul); 2022 Dec; 37(6):929-937. PubMed ID: 36604960
[TBL] [Abstract][Full Text] [Related]
19. Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study.
Cho MH; Yoo TG; Jeong SM; Shin DW
Cancer Prev Res (Phila); 2021 Jan; 14(1):95-104. PubMed ID: 32938643
[TBL] [Abstract][Full Text] [Related]
20. Impact of metformin use among tuberculosis close contacts with diabetes mellitus in a nationwide cohort study.
Lee MC; Lee CH; Lee MR; Wang JY; Chen SM
BMC Infect Dis; 2019 Nov; 19(1):936. PubMed ID: 31694558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]